Safety of intravenous tobramycin in combination with a variety of anti-pseudomonal antibiotics in children with cystic fibrosis

OBJECTIVES: Previous studies have examined renal safety of once daily intravenous tobramycin in individuals with cystic fibrosis. This has been mainly in combination with ceftazidime in an adolescent or adult population. In this report, we describe our institutional experience of once daily intraven...

Descripción completa

Detalles Bibliográficos
Autores principales: Deschamp, Ashley R, Pettit, Rebecca S, Donaldson, Jennifer A, Slaven, James E, Davis, Stephanie D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648079/
https://www.ncbi.nlm.nih.gov/pubmed/29085640
http://dx.doi.org/10.1177/2050312117736694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648079/
https://www.ncbi.nlm.nih.gov/pubmed/29085640
http://dx.doi.org/10.1177/2050312117736694

Ejemplares similares